Gilead Sciences Inc. (NASDAQ:GILD) is one of the most undervalued quality stocks to buy according to hedge funds. On July 25, the European Medicines Agency’s Committee for Medicinal Products for Human ...

Bausch Health is acquiring DURECT primarily for its lead asset, called larsucosterol. This novel therapeutic molecule is an ...

Discover key insights from Cytokinetics' Q2 2025 earnings call, including aficamten’s regulatory progress, launch plans, clinical milestones, and ...

For the first target addressed in the partnership, the two companies reported the successful delivery of AI-designed, ...

SPG302, a Potential First-in-Class Synaptic Regenerative Therapy, Showed Progress in Cognitive Outcome Measures and a Favorable Safety Profile LOS ...

THE European Medicines Agency on Friday recommended authorizing a twice-yearly injectable drug “lenacapavir” to prevent HIV and help end the virus’ transmission.

Doctors have been advised to seriously consider patients' heart health before prescribing a painkiller taken by millions to ...

HealthPresso TechnoMedia expands AI healthcare content platform HUMETA to UAE and US, raising $2M for precision medical ...

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

Q2 2025 revenue of €103.0 million for YORVIPATH®and €50.7 million for SKYTROFA®- TransCon® CNP (navepegritide) NDA under ...

Regulatory Reviews of Aficamten for Obstructive HCM Progressing in U.S., E.U. and China; Late-Cycle Meeting with U.S. FDA ...